Clinical Trial Update: Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

View source ↗

Summary

A completed clinical trial from The University of Texas Health Science Center investigating covalent tolerance induction to Factor VIII to predict inhibitors in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Hemophilia A | Status: COMPLETED